keyword
https://read.qxmd.com/read/38652594/mental-health-conditions-in-patients-with-systemic-lupus-erythematosus-a-systematic-review-and-meta-analysis
#1
JOURNAL ARTICLE
Xiaotong Liu, Xinlei Jia, Xiao Wang, Ya Bin Wei, Jia Jia Liu
OBJECTIVES: The reported prevalence of mental health conditions (MHCs) in people with systemic lupus erythematosus (SLE) ranges widely. Whether MHCs are associated with increased risk of SLE or the outcomes of the disease is unclear. This paper aimed to conduct an umbrella and updated meta-analysis of MHCs in people with SLE and to identify whether MHCs are associated with the risk of SLE or patient outcomes. METHODS: We comprehensively searched PubMed, Web of Science, and Embase databases to identify relevant studies published before June 2023...
April 23, 2024: Rheumatology
https://read.qxmd.com/read/38652590/major-cardiovascular-events-in-patients-with-cardiovascular-monosodium-urate-deposits-in-atherosclerotic-plaques
#2
JOURNAL ARTICLE
Julia Held, Christoph Schwabl, David Haschka, Sarah Maier, Gudrun Feuchtner, Gerlig Widmann, Christina Duftner, Günter Weiss, Andrea Klauser
OBJECTIVE: To determine the association of cardiovascular atherosclerotic plaque monosodium urate deposits with the occurrence of major cardiovascular events in gout and hyperuricemia patients. METHODS: This retrospective cohort study included patients with clinically suspicion of gout, who performed a dual energy computed tomography of the affected limb and thorax between June 1st, 2012 and December 5th, 2019. Clinical and laboratory parameters were retrieved from patientś charts...
April 23, 2024: Rheumatology
https://read.qxmd.com/read/38652403/antiphospholipid-patients-admitted-in-the-intensive-care-unit-what-must-the-rheumatologist-know
#3
REVIEW
Quentin Moyon, Alexis Mathian, Matthias Papo, Alain Combes, Zahir Amoura, Marc Pineton de Chambrun
PURPOSE OF THE REVIEW: Antiphospholipid syndrome (APS) is a rare systemic autoimmune disorder that can escalate into a 'thrombotic storm' called the catastrophic antiphospholipid syndrome (CAPS), frequently requiring ICU admission for multiple organ failure. This review aims to offer insight and recent evidence on critically-ill APS patients. RECENT FINDINGS: The CAPS classification criteria define this condition as the involvement of at least three organs/systems/tissues within less than a week, caused by small vessel thrombosis, in patients with elevated antiphospholipid antibodies levels...
April 23, 2024: Current Rheumatology Reports
https://read.qxmd.com/read/38652335/combination-of-sj%C3%A3-gren-s-syndrome-and-anti-ku-syndrome-complicated-by-the-development-of-mucosa-associated-lymphoid-tissue-lymphoma-case-review-and-systematic-review-of-the-literature
#4
REVIEW
Oksana Andreevna Golovina, Anna Vasilievna Torgashina, Vadim Romanovich Gorodetskiy, Evgenia Vladimirovna Sockol, Elena Georgievna Sagina
The frequency of antibodies to Ku varies in various autoimmune diseases. In 2019, Spielmann et al. identified two types of anti-Ku syndrome based on a hierarchical clustering analysis. Sjögren's syndrome occurs both in the first type of anti-Ku syndrome and in the second type. Despite the fact that increased tissue expression of Ku proteins was noted in lymphocytic cells with focal sialoadenitis of the minor salivary glands in patients with primary Sjogren's syndrome, only 49 cases of a combination of anti-Ku antibodies and manifestations of Sjogren's syndrome have been described in the literature...
April 23, 2024: Clinical Rheumatology
https://read.qxmd.com/read/38651512/an-update-on-topical-therapies-for-psoriasis
#5
JOURNAL ARTICLE
Emily K Pender, Brian Kirby
PURPOSE OF REVIEW: Topical therapies are a mainstay of treatment for mild psoriasis and may be a useful adjunct in treatment of moderate-to-severe psoriasis. This review summarizes recent advances in topical therapies for psoriasis and currently available treatments. RECENT FINDINGS: Topical aryl hydrocarbon receptor modulators (tapinarof) and topical phosphodiesterase-4 inhibitors (roflumilast) have been proven effective in randomized controlled trials for psoriasis...
April 24, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38644073/myofascial-pain-a-major-player-in-musculoskeletal-pain
#6
REVIEW
Christopher Lam, Vinicius Tieppo Francio, Kelsey Gustafson, Michael Carroll, Abigail York, Andrea L Chadwick
Myofascial pain is a soft tissue pain syndrome with local and referred musculoskeletal pain arising from trigger points. Myofascial pain and myofascial pain syndromes are among some of the most common acute and chronic pain conditions. Myofascial pain can exist independently of other pain generators or can coexist with or is secondary to other acute and chronic painful musculoskeletal conditions. Myofascial pain is most effectively treated with a multimodal treatment plan including injection therapy (known as trigger point injections, physical therapy, postural or ergonomic correction, and treatment of underlying musculoskeletal pain generators...
April 20, 2024: Best Practice & Research. Clinical Rheumatology
https://read.qxmd.com/read/38641628/nonbacterial-thrombotic-endocarditis-of-mitral-valve-associated-with-a-lymphoproliferative-malignancy-case-report-and-literature-review
#7
JOURNAL ARTICLE
Fabiana Duarte, Maria Inês Barradas, Ana Raquel Dias, Carlos Faria, Carina Machado, Carolina Pavão
BACKGROUND: Non-bacterial thrombotic endocarditis (NBTE) is a rare condition marked by sterile vegetations on cardiac valves, often linked to rheumatologic diseases, autoimmune disorders, and advanced solid malignancies. An early diagnosis and treatment of the associated clinical condition are mandatory, although they do not usually eliminate valvular vegetations, making anticoagulation essential to prevent embolic events. Despite variability, the prognosis of NBTE is usually unfavorable due to recurrent embolic events and the severity of the primary condition, typically advanced cancer...
April 19, 2024: Cardio-Oncology
https://read.qxmd.com/read/38639758/drug-therapy-in-juvenile-spondyloarthritis
#8
JOURNAL ARTICLE
Hemalatha Srinivasalu, Jessica Simpson, Matthew L Stoll
PURPOSE OF REVIEW: This review summarizes latest developments in treatment of juvenile spondyloarthritis (JSpA), specifically enthesitis-related arthritis (ERA) and juvenile psoriatic arthritis (JPsA). RECENT FINDINGS: There has been addition of biologic disease modifying antirheumatic drugs (bDMARDs) beyond tumor necrosis factor inhibitors (TNFi) for JSpA such as IL-17 blockers, IL-23 blockers, and janus activating kinase inhibitors with favorable safety profile...
April 22, 2024: Current Opinion in Rheumatology
https://read.qxmd.com/read/38632528/immune-checkpoint-inhibitors-in-cancer-patients-with-rheumatologic-preexisting-autoimmune-diseases-a-systematic-review-and-meta-analysis
#9
Xin Liu, Su Li, Liyuan Ke, Hongxia Cui
BACKGROUND: Patients with rheumatologic preexisting autoimmune disease (PAD) have not been enrolled in clinical trials of immune checkpoint inhibitors (ICIs). Therefore, the risks and benefits of ICI therapy in such patients are unclear. Herein, we investigated the safety and efficacy of ICIs in rheumatologic PAD patients through a meta-analysis. METHODS: The PubMed, Cochrane Library, Embase and Web of Science databases were searched for additional studies. We analyzed the following data through Stata software: incidence of total irAEs (TirAEs), rate of flares, incidence of new on-set irAEs, rate of discontinuation, objective response rate (ORR) and disease control rate (DCR)...
April 17, 2024: BMC Cancer
https://read.qxmd.com/read/38631525/limb-arteries-involvement-assessed-by-fdg-pet-ct-at-diagnosis-of-giant-cell-arteritis-and-risk-of-relapse-an-observational-study
#10
JOURNAL ARTICLE
Geoffroy Peyrac, Arthur Mageau, Augustin Gaudemer, Khadija Benali, Julien Rohmer, Jean-Francois Alexandra, Andrey Strukov, Sebastien Ottaviani, Thomas Papo, Karim Sacre
Introduction Steroids and anti-IL6 biotherapy are highly effective in obtaining remission in patients with giant cell arteritis (GCA) but the risk of relapses remains high. We aimed to identify predictors of relapse in GCA. Methods All consecutive patients admitted with a new diagnosis of GCA - according to the 2022 American College of Rheumatology/EULAR (ACR/EULAR) classification criteria - between May 2011 and May 2022 were eligible for this study. The primary outcome was the GCA relapse rate over the 36-months follow up...
April 15, 2024: Joint, Bone, Spine: Revue du Rhumatisme
https://read.qxmd.com/read/38631369/diagnostic-approach-to-interstitial-lung-diseases-associated-with-connective-tissue-diseases
#11
JOURNAL ARTICLE
Ana C Zamora, Lewis J Wesselius, Michael B Gotway, Henry D Tazelaar, Alejandro Diaz-Arumir, Vivek Nagaraja
Interstitial lung disorders are a group of respiratory diseases characterized by interstitial compartment infiltration, varying degrees of infiltration, and fibrosis, with or without small airway involvement. Although some are idiopathic (e.g., idiopathic pulmonary fibrosis, idiopathic interstitial pneumonias, and sarcoidosis), the great majority have an underlying etiology, such as systemic autoimmune rheumatic disease (SARD, also called Connective Tissue Diseases or CTD), inhalational exposure to organic matter, medications, and rarely, genetic disorders...
April 17, 2024: Seminars in Respiratory and Critical Care Medicine
https://read.qxmd.com/read/38629371/translation-research-in-therapeutic-approaches-from-conventional-to-novel-nano-therapeutics-for-rheumatoid-arthritis-treatment
#12
JOURNAL ARTICLE
Laxmi Rani, Pooja Mathur, Ravinder Verma, Vivek Kumar, Ashwini Kumar Mishra, Pravat Kumar Sahoo
Rheumatoid arthritis is a systemic autoimmune disorder related to joint inflammation, bone erosion, and deformity. Numerous studies indicate that the causes and consequences of RA are still being debated, and therapeutic strategies are in the translation stage. Non-steroidal anti-inflammatory drugs continue to be often used to relieve pain. Still, due to their poor efficacy, failure to halt the spread of the disease, and undesirable adverse effects, they are no longer regarded as first-line treatments. The development of biologic DMRDs designed to reduce the inflammatory response led to substantial changes to the strategy for managing this disease...
April 15, 2024: Current Rheumatology Reviews
https://read.qxmd.com/read/38629107/a-content-analysis-of-medication-adherence-material-in-patient-educational-resources-about-gout
#13
JOURNAL ARTICLE
Yasaman Emad, Christina Derksen, Keith J Petrie, Nicola Dalbeth
OBJECTIVE: This study aimed to investigate how medication adherence is addressed in online gout resources in six countries. We investigated how often adherence was referred to, the strategies suggested to improve patient adherence, and the types of nonadherence that were targeted. We also examined the readability of the adherence material. METHODS: A content analysis was conducted on 151 online gout resources from medical and health organisations in six predominantly English-speaking countries...
2024: Rheumatology Advances in Practice
https://read.qxmd.com/read/38629069/higher-odds-of-periodontitis-in-systemic-lupus-erythematosus-compared-to-controls-and-rheumatoid-arthritis-a-systematic-review-meta-analysis-and-network-meta-analysis
#14
Ping Ren Tan, Aaron J L Lee, Joseph J Zhao, Yiong Huak Chan, Jia Hui Fu, Margaret Ma, Sen Hee Tay
INTRODUCTION: Periodontitis as a comorbidity in systemic lupus erythematosus (SLE) is still not well recognized in the dental and rheumatology communities. A meta-analysis and network meta-analysis were thus performed to compare the (i) prevalence of periodontitis in SLE patients compared to those with rheumatoid arthritis (RA) and (ii) odds of developing periodontitis in controls, RA, and SLE. METHODS: Pooled prevalence of and odds ratio (OR) for periodontitis were compared using meta-analysis and network meta-analysis (NMA)...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38627861/unveiling-the-clinical-spectrum-of-relapsing-polychondritis-insights-into-its-pathogenesis-novel-monogenic-causes-and-therapeutic-strategies
#15
REVIEW
Blanca E R G Bica, Alexandre Wagner S de Souza, Ivânio Alves Pereira
Relapsing polychondritis is a rare multisystem disease involving cartilaginous and proteoglycan-rich structures. The diagnosis of this disease is mainly suggested by the presence of flares of inflammation of the cartilage, particularly in the ears, nose or respiratory tract, and more rarely, in the presence of other manifestations. The spectrum of clinical presentations may vary from intermittent episodes of painful and often disfiguring auricular and nasal chondritis to an occasional organ or even life-threatening manifestations such as lower airway collapse...
April 16, 2024: Advances in Rheumatology
https://read.qxmd.com/read/38627860/hemophagocytic-lymphohistiocytosis-and-macrophage-activation-syndrome-two-rare-sides-of-the-same-devastating-coin
#16
REVIEW
Flavio Sztajnbok, Adriana Rodrigues Fonseca, Leonardo Rodrigues Campos, Kátia Lino, Marta Cristine Félix Rodrigues, Rodrigo Moulin Silva, Rozana Gasparello de Almeida, Sandro Félix Perazzio, Margarida de Fátima Fernandes Carvalho
Hemophagocytic lymphohistiocytosis (HLH) is a rare genetic hyperinflammatory syndrome that occurs early in life. Macrophage activation syndrome (MAS) usually refers to a secondary form of HLH associated with autoimmunity, although there are other causes of secondary HLH, such as infections and malignancy. In this article, we reviewed the concepts, epidemiology, clinical and laboratory features, diagnosis, differential diagnosis, prognosis, and treatment of HLH and MAS. We also reviewed the presence of MAS in the most common autoimmune diseases that affect children...
April 16, 2024: Advances in Rheumatology
https://read.qxmd.com/read/38627367/bilateral-tibial-fractures-associated-with-powered-exoskeleton-use-in-complete-spinal-cord-injury-a-case-report-literature-review
#17
JOURNAL ARTICLE
John Mahon, Lily Nolan, David O'Sullivan, Mark Curtin, Aiden Devitt, Colin G Murphy
INTRODUCTION: Powered robotic exoskeleton (PRE) physiotherapy programmes are a relatively novel frontier which allow patients with reduced mobility to engage in supported walking. Research is ongoing regarding their utility, risks, and benefits. This article describes the case of two fractures occurring in one patient using a PRE. CASE: We report the case of a 54 year old man who sustained bilateral tibial fractures while using a PRE, on a background of T10 AIS A SCI...
April 16, 2024: Spinal Cord Series and Cases
https://read.qxmd.com/read/38627280/management-of-granulomatosis-with-polyangiitis-complicated-by-intestinal-perforation-and-pancytopenia-a-case-report-and-literature-review
#18
REVIEW
Svitlana Smiyan, Olena Dyadyk, Oksana Kvasnitska, Olexandra Makhovska, Zhanna Antiuk, Taras Bidovanets, Roman Komorovsky
Granulomatosis with polyangiitis is a systemic vasculitis. While the classic triad typically comprises otorhinolaryngologic, pulmonary, and renal manifestations, it is essential to recognize that granulomatosis with polyangiitis can affect any organ. Furthermore, reports have documented less common sites of involvement, such as the gastrointestinal tract. In this case-based review, we focus on a case of granulomatosis with polyangiitis presenting with intestinal perforation and the added challenge of concurrent pancytopenia...
April 17, 2024: Rheumatology International
https://read.qxmd.com/read/38625674/peripheral-ulcerative-keratitis-associated-with-tralokinumab-therapy-a-case-report-and-review-of-il-13-inhibitor-associated-ocular-surface-disease
#19
JOURNAL ARTICLE
Nenita Maganti, Samuel A Whittier, Evan J Warner
BACKGROUND: Dupilumab and tralokinumab are interleukin-binding monoclonal antibodies used to treat systemic atopic disease. Use of these medications in management of atopic dermatitis (AD) is known to cause conjunctivitis. Dupilumab therapy has also been associated with more severe ocular surface disease, which has not previously been described in association with tralokinumab. This report describes a case of tralokinumab-associated conjunctivitis and peripheral ulcerative keratitis and reviews the spectrum and proposed mechanisms of ocular surface disease triggered by these medications...
April 16, 2024: Journal of Ophthalmic Inflammation and Infection
https://read.qxmd.com/read/38625385/renal-manifestations-in-adult-onset-still-s-disease-a-systematic-review
#20
P V Akhila Arya, Erica Marnet, Madhumita Rondla, Jia Wei Tan, Dileep Unnikrishnan, Gregory Buller
OBJECTIVE: We aimed to review the literature on the clinical presentation, renal pathology, treatment, and outcome of renal manifestations in adult-onset Still's disease (AOSD). METHODS: We used PRISMA guidelines for our systematic review and included all English-language original articles from inception till September 15, 2023, on AOSD and kidney involvement in any form. Data on patient demographics, diagnostic criteria, clinical presentation, renal pathology, treatment employed including dialysis, outcome, cause of death were collected and analyzed...
April 16, 2024: Rheumatology International
keyword
keyword
108211
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.